Advertisement
Screener

BioLife Solutions, Inc. (BLFS) Proceeds from Issuance of Private Placement

2.4 / 5 stars · 45/93 Roast Me

BioLife Solutions, Inc. Proceeds from Issuance of Private Placement

BioLife Solutions, Inc. (BLFS) reported Proceeds from Issuance of Private Placement of $20.00 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-05-15.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2020-05-15

  • BioLife Solutions, Inc. proceeds from issuance of private placement for the quarter ending 2018-12-31 was $0.00.
  • BioLife Solutions, Inc. proceeds from issuance of private placement for fiscal 2018 was $20.00M.
Period endProceeds from Issuance of Private Placement 3 monthProceeds from Issuance of Private Placement 9 monthProceeds from Issuance of Private Placement 9 month as first filedProceeds from Issuance of Private Placement 12 month
2018-12-31$0.00
derived: 10-K 12 month − 10-K 9 month · filed 2020-05-15
$20.00M
10-K · filed 2020-05-15
2018-09-30$20.00M
10-K · filed 2020-05-15
$20.00M
10-Q · filed 2018-11-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
Axogen, Inc. (AXGN)United States$2.329B-73.83
CONMED Corp (CNMD)United States$1.353B26.72
Ceribell, Inc. (CBLL)United States$0.916B-11.27
TransMedics Group, Inc. (TMDX)United States$2.911B15.17
CapsoVision, Inc (CV)United States$0.310B-12.68
Electromed, Inc. (ELMD)United States$0.233B31.13
EDAP TMS SA (FOCL)$0.171B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
Vivani Medical, Inc. (VANI)United States$0.111B
electroCore, Inc. (ECOR)United States$0.102B